脑脊液生物标志物预测阿尔茨海默病的发病和进展

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-04-28 DOI:10.1038/s41591-025-03700-z

引用次数: 0

摘要

对人类脑脊液中数千种蛋白质的蛋白质组学分析表明，两种蛋白质的比例可用于预测阿尔茨海默病脑病理患者未来的痴呆或认知恢复能力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Cerebrospinal fluid biomarker predicts dementia onset and progression in Alzheimer’s disease

查看原文本刊更多论文

Cerebrospinal fluid biomarker predicts dementia onset and progression in Alzheimer’s disease

Proteomics analyses of thousands of proteins in human cerebrospinal fluid reveal that the ratio of two proteins can be used to predict future dementia or cognitive resilience among people with Alzheimer’s disease brain pathology.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.